15 April 2026
Trump Administration Pivots to Section 301 Tariffs After Supreme Court Strikes Down IEEPA Measures on China
China Tariff News and Tracker
About
Welcome to China Tariff News and Tracker, where we break down the latest developments in US-China trade tensions under President Trump.
In a whirlwind response to the Supreme Court striking down IEEPA tariffs on February 20, 2026, the Trump administration has pivoted aggressively. Baker Botts reports that current Section 122 tariffs impose a 10 percent ad valorem duty on all Chinese products, down from an original 20 percent rate implemented in March 2025, though these are set to expire July 24, 2026. This follows a federal court ruling in Learning Resources, Inc. v. Trump, deeming IEEPA tariffs unconstitutional and opening refunds via CBP's CAPE portal starting April 20 for certain entries.
China-specific measures remain laser-focused. Section 301 tariffs hit 100 percent on cranes and cargo handling equipment from China, implemented October 2025 but briefly suspended. ISM notes the seismic shift away from China, with supply chains rerouting to Vietnam, Malaysia, and Mexico amid average US tariffs now at 11 percent per Yale Budget Lab, costing households $760 to $940 annually. Fortune highlights how these tariffs have delivered an economic blow to all 50 states, with US businesses and consumers absorbing nearly 90 percent of costs by 2026, per Federal Reserve research.
Looking ahead, Wipfli warns of looming Section 301 investigations targeting around 100 countries, potentially reinstating higher China rates by summer. Treasury Secretary Scott Bessent told the Wall Street Journal tariffs could return to pre-ruling levels by July via Section 301, already court-tested. Bloomberg adds US trade chief Greer announced tech restrictions to block Chinese autos, signaling no thaw in Beijing-Washington friction.
Meanwhile, broader Section 232 hikes effective April 2—like 50 percent on steel, aluminum, and copper—spare few, but pharma tariffs at 100 percent on patented drugs and APIs from non-preferred nations, including China, kick in July 31, per White House proclamations cited by JD Supra.
These moves underscore Trump's unrelenting push to reshape global trade, with China squarely in the crosshairs.
Thanks for tuning in, listeners—subscribe now for weekly updates. This has been a Quiet Please production, for more check out quietplease.ai.
For more check out https://www.quietperiodplease.com/
Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q
This content was created in partnership and with the help of Artificial Intelligence AI
This episode includes AI-generated content.
In a whirlwind response to the Supreme Court striking down IEEPA tariffs on February 20, 2026, the Trump administration has pivoted aggressively. Baker Botts reports that current Section 122 tariffs impose a 10 percent ad valorem duty on all Chinese products, down from an original 20 percent rate implemented in March 2025, though these are set to expire July 24, 2026. This follows a federal court ruling in Learning Resources, Inc. v. Trump, deeming IEEPA tariffs unconstitutional and opening refunds via CBP's CAPE portal starting April 20 for certain entries.
China-specific measures remain laser-focused. Section 301 tariffs hit 100 percent on cranes and cargo handling equipment from China, implemented October 2025 but briefly suspended. ISM notes the seismic shift away from China, with supply chains rerouting to Vietnam, Malaysia, and Mexico amid average US tariffs now at 11 percent per Yale Budget Lab, costing households $760 to $940 annually. Fortune highlights how these tariffs have delivered an economic blow to all 50 states, with US businesses and consumers absorbing nearly 90 percent of costs by 2026, per Federal Reserve research.
Looking ahead, Wipfli warns of looming Section 301 investigations targeting around 100 countries, potentially reinstating higher China rates by summer. Treasury Secretary Scott Bessent told the Wall Street Journal tariffs could return to pre-ruling levels by July via Section 301, already court-tested. Bloomberg adds US trade chief Greer announced tech restrictions to block Chinese autos, signaling no thaw in Beijing-Washington friction.
Meanwhile, broader Section 232 hikes effective April 2—like 50 percent on steel, aluminum, and copper—spare few, but pharma tariffs at 100 percent on patented drugs and APIs from non-preferred nations, including China, kick in July 31, per White House proclamations cited by JD Supra.
These moves underscore Trump's unrelenting push to reshape global trade, with China squarely in the crosshairs.
Thanks for tuning in, listeners—subscribe now for weekly updates. This has been a Quiet Please production, for more check out quietplease.ai.
For more check out https://www.quietperiodplease.com/
Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q
This content was created in partnership and with the help of Artificial Intelligence AI
This episode includes AI-generated content.